venrock healthcare capital partners iii, l.p.
530 FIFTH AVENUE, 22ND FLOOR
NEW YORK
NY
10036
Business Phone:
212-444-4100
Current 13D/G Holdings
Stock |
Sector |
Shares Held |
Market Value |
Rank |
Source |
Source Date |
Viridian Therapeutics Inc (VRDN)
|
HEALTH CARE
|
4,230,621
|
123,576,439.41
|
1
|
13G
|
2022-12-31
|
Ambrx Biopharma Inc (AMAM)
|
HEALTH CARE
|
26,740,000
|
74,337,200.00
|
2
|
13G
|
2023-02-16
|
Terns Pharmaceuticals Inc (TERN)
|
HEALTH CARE
|
3,707,891
|
37,746,330.38
|
3
|
13G
|
2022-12-31
|
KalVista Pharmaceuticals Inc (KALV)
|
HEALTH CARE
|
2,916,667
|
19,716,668.92
|
4
|
13G
|
2022-12-28
|
Cabaletta Bio, Inc. (CABA)
|
HEALTH CARE
|
1,895,285
|
17,531,386.25
|
5
|
13G
|
2022-12-13
|
Enliven Therapeutics Inc (ELVN)
|
HEALTH CARE
|
2,214,142
|
13,993,377.44
|
6
|
13G
|
2023-03-03
|
Milestone Pharmaceuticals Inc (MIST)
|
HEALTH CARE
|
2,208,812
|
8,746,895.52
|
7
|
13G
|
2022-12-31
|
Avalo Therapeutics Inc (AVTX)
|
HEALTH CARE
|
1,352,285
|
4,678,906.10
|
8
|
13G
|
2023-02-07
|
Active Schedule 13D and 13G events
Sign in to see